These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of the metabolic effects of chlormadinone acetate and conventional contraceptive steroids in man. Beck P J Clin Endocrinol Metab; 1970 Jun; 30(6):785-91. PubMed ID: 4192202 [No Abstract] [Full Text] [Related]
8. Effect of aggregating agents on platelet electrophoretic mobility. Hampton JR; Mitchell JR Thromb Diath Haemorrh Suppl; 1967; 26():69-70. PubMed ID: 6064878 [No Abstract] [Full Text] [Related]
9. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial. Howard G; Blair M; Elstein M; Morris NF Lancet; 1969 Jul; 2(7610):24-6. PubMed ID: 4182794 [No Abstract] [Full Text] [Related]
10. Contraceptive treatment with chlormadinone and its effect on the endometrium. A histological investigation. Kühne D; Seidl S; Göretzlehner G Endokrinologie; 1972 May; 59(3):295-306. PubMed ID: 4116092 [TBL] [Abstract][Full Text] [Related]
11. The alteration of surface charge characteristics of the vascular system by oral contraceptive steroids. Srinivasan S; Solash J; Redner A; Moser C; Farhangian D; Lucas TR; Ateyeh E; McCool CT+MACCOOL CT; Weber D; Puvan SI; Jones JR; Sawyer PN Contraception; 1974 Mar; 9(3):291-303. PubMed ID: 4442278 [No Abstract] [Full Text] [Related]
13. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study. Poller L; Thomson JM; Thomas W; Wray C Br Med J; 1971 Mar; 1(5751):705-7. PubMed ID: 4101481 [TBL] [Abstract][Full Text] [Related]
14. [Changes in plasma lipids caused by oral contraceptives]. Kaffarnik H Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609 [No Abstract] [Full Text] [Related]
15. Plasma proteins after continuous, oral use of a progestogen--chloromadionone acetate--as a contraceptive. Laurell CB; Kullander S; Thorell J Scand J Clin Lab Invest; 1969 Dec; 24(4):387-9. PubMed ID: 4192239 [No Abstract] [Full Text] [Related]
16. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics]. Gödel E; Gödel B Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543 [No Abstract] [Full Text] [Related]
17. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol". Farbiszewski R; Kurowska T Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970 [No Abstract] [Full Text] [Related]
18. [Lipid metabolism in women ingesting gestagens as contraceptives]. Pisarek-Miedzińska D; Roszkowski I; Firek A Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343 [No Abstract] [Full Text] [Related]
19. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system]. Carol W; Klinger G; Hempel E; Starker K; Quent P Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364 [No Abstract] [Full Text] [Related]
20. [Modification of the thrombocyte function using hormonal contraception. 1. Thrombocyte count, thrombocyte propagation and platelet aggregation under hormonal contraception]. Traub RF; Brandt M; Hofmann KD Zentralbl Gynakol; 1976; 98(3):161-5. PubMed ID: 61668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]